Palantir Nearly Doubled Its Revenue. Its Stock Stood Still. Is It Time to Buy the Stock?

Palantir's Q2 revenue rose 93% year over year to $1.94 billion, while operating income more than tripled to $912 million and operating margin expanded 2,000bps to 47%. Management raised its 2026 revenue target twice to $8.15 billion, versus a $4.15 billion 2025 target at the same point a year earlier, supported by 149% growth in U.S. commercial revenue and $6.2 billion of remaining deal value. However, despite its flat share price near $176, Palantir still trades at roughly 52x guided sales and 76x forward earnings, leaving the stock vulnerable to any material growth deceleration.

Analysis

PLTR's setup is now dominated by duration risk rather than execution risk: the market is capitalizing several years of exceptional growth and margin expansion up front. At ~52x forward sales, even a sustained 40-50% revenue CAGR would likely produce limited upside unless operating margins continue to exceed mature software peers or the company establishes a credible path to a materially larger commercial platform. The near-term asymmetry is negative because another beat that merely maintains guidance is unlikely to reset estimates enough, while a deceleration in U.S. commercial bookings, conversion of remaining deal value, or federal award timing could compress the multiple sharply.

The second-order issue is competitive: PLTR's rapid commercial adoption validates demand for production AI software, benefiting cloud and model-infrastructure vendors such as MSFT, AMZN, ORCL and NVDA, but it also invites budget scrutiny. As enterprises move from pilots to scaled deployment, customers will increasingly compare Palantir's integrated platform economics against internally built stacks using hyperscaler tooling and cheaper data platforms. That raises the importance of net retention, implementation capacity, and sales efficiency—not just headline contract value—over the next 2-4 quarters.

Contrarian upside is that conventional SaaS valuation frameworks may understate operating leverage if AIP becomes a standard enterprise control layer with unusually low incremental deployment costs. That outcome requires evidence that commercial growth remains above 50% through 2027 while margins hold near current levels; absent that, the stock can de-rate despite continued fundamental growth. A flat-to-down share price through several more estimate upgrades would improve the risk/reward materially, but current levels offer little cushion against even modest guidance conservatism.

Key Decisions for Investors

• Maintain PLTR as underweight/avoid fresh directional longs into the next earnings print. Reassess only after a 25-35% pullback or if forward revenue estimates rise enough to bring the sales multiple below ~35x; downside from multiple compression exceeds likely upside from a routine beat over 1-3 months.
• For a tactical bearish expression, consider a 3-6 month PLTR put spread rather than outright short exposure: target a move toward the prior $106-$125 trading zone, with risk capped to premium if commercial growth and guidance continue accelerating. Size modestly because momentum and retail ownership can sustain valuation extremes.
• Pair long MSFT or AMZN versus short PLTR over 6-12 months for AI-enterprise exposure with lower valuation-duration risk. The pair is invalidated if PLTR demonstrates durable superior commercial growth and net retention while hyperscaler AI software revenue fails to monetize.
• Set an earnings watchlist around U.S. commercial remaining deal value growth, deal conversion timing, net retention, and 2027 revenue commentary. A material slowdown in booked-value growth or guidance that implies sub-50% commercial growth is the clearest catalyst for de-rating; sustained acceleration would falsify the short bias.